https://www.southampton.ac.uk/shtac/news/latest.pageSHTAC News FeedSHTAC is presenting at the Health Technology Assessment (HTA) International conference, Cologne, 18th June 2019https://cdn.southampton.ac.uk/assets/imported/transforms/site/news-release/PageThumbnail/C9647BA08F794D85ACE0C1194142A877/research graphic news.jpg_SIA_JPG_fit_to_width_XL.jpghttps://www.southampton.ac.uk/shtac/news/2019/06/18-htai-conference-2019.pageThe oral presentation, given by Dr Jonathan Shepherd, will describe the scope, methods and findings of a recently completed systematic map conducted by researchers at SHTAC.https://www.southampton.ac.uk/shtac/news/2019/06/18-htai-conference-2019.pageTue, 18 Jun 2019 00:00:00 +0100NICE guidance informed by SHTAC report on atezolizumab in combination for treating advanced non-squamous non-small-cell lung cancer https://cdn.southampton.ac.uk/assets/imported/transforms/site/news-release/PageThumbnail/F4E8ECFC0EA54597AB2E37ACD5D8B39E/lung cancer.jpg_SIA_JPG_fit_to_width_XL.jpghttps://www.southampton.ac.uk/shtac/news/2019/06/5-nice-guidance-informed-by-shtac-report.pageThe National Institute for Health and Care Excellence (NICE) has issued guidance to the National Health Service (NHS) on the use of the atezolizumab in combination for treating advanced non-squamous non-small-cell lung cancer, informed by a report produced by SHTAC. https://www.southampton.ac.uk/shtac/news/2019/06/5-nice-guidance-informed-by-shtac-report.pageWed, 05 Jun 2019 00:00:00 +0100SHTAC are recruiting a Research Fellow in Information Science and Evidence Synthesishttps://cdn.southampton.ac.uk/assets/imported/transforms/site/news-release/PageThumbnail/2A855A02AAC64518800BC19F79F0D44B/join our team resized.jpg_SIA_JPG_fit_to_width_XL.jpghttps://www.southampton.ac.uk/shtac/news/2019/05/research-fellow-opportunity.pageWe are seeking a person with good skills in information science and good knowledge of, and/or demonstrable skills in conducting systematic reviews to join our team supporting national health policy decisions about the effective and cost-effective use of medicines and other healthcare technologies. https://www.southampton.ac.uk/shtac/news/2019/05/research-fellow-opportunity.pageThu, 23 May 2019 00:00:00 +0100NICE guidance informed by SHTAC report on daratumumab with bortezomib and dexamethasone for previously treated multiple myelomahttps://cdn.southampton.ac.uk/assets/imported/transforms/site/news-release/PageThumbnail/443D37A4EA4A4C31AEE884711A27628D/intravenous-dripjpg.jpg_SIA_JPG_fit_to_width_XL.jpghttps://www.southampton.ac.uk/shtac/news/2019/05/2-nice-guidance-issued-daratumumab.pageThe National Institute for Health and Care Excellence (NICE) has issued guidance to the National Health Service (NHS) on the use of the drugs daratumumab with bortezomib and dexamethasone as a treatment for previously treated multiple myeloma in adults, informed by a report produced by SHTAC. https://www.southampton.ac.uk/shtac/news/2019/05/2-nice-guidance-issued-daratumumab.pageThu, 02 May 2019 00:00:00 +0100SHTAC is the new chair of InterTASC – the hub for the groups providing independent health technology assessments (HTA) for NICE and the NIHRhttps://cdn.southampton.ac.uk/assets/imported/transforms/site/news-release/PageThumbnail/70458762A43F41BE83562CCDB2C9C6DC/intertasc-header-2000x1200.jpg_SIA_JPG_fit_to_width_XL.jpghttps://www.southampton.ac.uk/shtac/news/2019/04/25intertasc.pageSHTAC will chair InterTASC business meetings twice a year and co-ordinate other activities such as training workshops, and liaise with NICE and NIHR on methods and processes in HTA. https://www.southampton.ac.uk/shtac/news/2019/04/25intertasc.pageThu, 25 Apr 2019 00:00:00 +0100